Sometimes chemists are able to propose two or more mechanisms that are consistent with the available data. name: 2,3-Dichloroquinoxaline, If a proposed mechanism predicts the wrong experimental rate law, however, the mechanism must be incorrect.Welcome to check out more blogs about 2213-63-0, in my other articles.
One of the major reasons for studying chemical kinetics is to use measurements of the macroscopic properties of a system, name: 2,3-Dichloroquinoxaline, such as the rate of change in the concentration of reactants or products with time.In a article, mentioned the application of 2213-63-0, Name is 2,3-Dichloroquinoxaline, molecular formula is C8H4Cl2N2
Synthesis and characterization of polyaromatic azine derivatives of (eta5-C5H5) Fe(CO)2 and (eta5-C9H7) Fe(CO)2
The synthesis and characterization of 14 monometallic derivatives of quinoline, quinoxaline, quinazoline and tetraazolo<1,5-A>quinoline and a bimetallic derivative of quinoxaline are reported. These species were prepared in 11 to 88% isolated yields by metathesis reactions between NaFp or NaFp? (where Fp = (eta5 – C5H5)Fe(CO)2 and Fp? = (eta5 – indenyl)Fe(CO)2 ) and the appropriate chlorine substituted polyaromatic azines. These reactions are highly regioselective and generally produce a single organometallic product having the organometallic substituent(s) bonded to the more highly activated azine ring. The structures of three representative examples were confirmed by their X-ray crystal structures, which are reported for the title complexes 4-[(eta5-cyclopentadienyl)irondicarbonyl]-7-chloroquinoline (C16H10ClFeNO2; a = 7.608(1)A, b = 12.006(1)A, c = 15.664(1)A, V = 1431A3; orthorhombic; P212121; Z =4), 2-[(eta5-cyclopentadienyl)irondicarbonyl]-3-chloroquinoxaline (C15H9ClFeN2O2; a = 15.291(3) A, b = 6.561(2) A, c = 14.541(4) A, beta = 106.891(21), V= 1395.9A3; monoclinic; P21/c; Z = 4), and 2-[(eta5-indenyl)irondicarbonyl]-3-chloroquinoxaline (C19H11ClFeN2O2; a = 19.131(2)A, b = 6.688(1)A, c = 13.515(2) A, beta= 101.569(11), V = 1694.1 A3; monoclinic; P21/c; Z = 4). The bimetallic quinoxaline derivative 2,3-[(C5H5)2Fe2(CO)4]-quinoxaline has orrto-substituted organometallic groups and the spectroscopic data suggest that it has an unusual structure in solution, perhaps involving bridging cyclopentadienyl and carbonyl ligands.
Sometimes chemists are able to propose two or more mechanisms that are consistent with the available data. name: 2,3-Dichloroquinoxaline, If a proposed mechanism predicts the wrong experimental rate law, however, the mechanism must be incorrect.Welcome to check out more blogs about 2213-63-0, in my other articles.
Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1362 | ChemSpider